Home/Filings/4/0001651308-24-000100
4//SEC Filing

Rosenberg Aaron 4

Accession 0001651308-24-000100

CIK 0001651308other

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 5:17 PM ET

Size

7.6 KB

Accession

0001651308-24-000100

Insider Transaction Report

Form 4
Period: 2024-08-09
Rosenberg Aaron
Chief Financial Officer
Transactions
  • Award

    Ordinary Shares

    2024-08-09+118,547118,547 total
  • Award

    Share Option (Right to Buy)

    2024-08-09+220,987220,987 total
    Exercise: $14.06Exp: 2034-08-08Ordinary Shares (220,987 underlying)
Footnotes (3)
  • [F1]Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of July 31, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
  • [F2]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.
  • [F3]These securities vest over a four-year period as follows: 25% on the first anniversary of July 31, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Issuer

BeiGene, Ltd.

CIK 0001651308

Entity typeother

Related Parties

1
  • filerCIK 0002031182

Filing Metadata

Form type
4
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 5:17 PM ET
Size
7.6 KB